We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

42 hedge funds and large institutions have $60.9M invested in Enanta Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
+42
Holders Change %
–
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
42
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AP
1
AlpInvest Partners
Netherlands
$9.62M +$10.6M +543,401 New
Franklin Resources
2
Franklin Resources
California
$8.5M +$9.36M +479,900 New
RCM
3
RA Capital Management
Massachusetts
$7.72M +$8.5M +436,145 New
Wellington Management Group
4
Wellington Management Group
Massachusetts
$6M +$6.61M +338,791 New
WSA
5
Wall Street Associates
California
$4.65M +$5.12M +262,800 New
BIT
6
BlackRock Institutional Trust
California
$3.25M +$3.58M +183,633 New
Barclays
7
Barclays
United Kingdom
$3.18M +$3.5M +179,569 New
BI
8
BVF Inc
California
$2.72M +$2.99M +153,500 New
BBA
9
Baker Bros. Advisors
New York
$2.21M +$2.44M +125,000 New
SONJCPFA
10
State of New Jersey Common Pension Fund A
New Jersey
$1.99M +$2.19M +112,500 New
BFA
11
BlackRock Fund Advisors
California
$1.63M +$1.79M +91,844 New
TI
12
Turner Investments
Pennsylvania
$1.58M +$1.74M +89,200 New
KCM
13
Kingdon Capital Management
New York
$1.33M +$1.46M +75,000 New
BA
14
BlackRock Advisors
Delaware
$779K +$858K +43,998 New
Morgan Stanley
15
Morgan Stanley
New York
$773K +$852K +43,678 New
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
$633K +$696K +35,720 New
Vanguard Group
17
Vanguard Group
Pennsylvania
$546K +$601K +30,826 New
PAM
18
Panagora Asset Management
Massachusetts
$407K +$448K +22,972 New
TC
19
TFS Capital
Pennsylvania
$392K +$432K +22,149 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$369K +$406K +20,821 New
FCH
21
Freestone Capital Holdings
Washington
$358K +$394K +20,200 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$310K +$341K +17,497 New
Deutsche Bank
23
Deutsche Bank
Germany
$296K +$328K +16,799 New
TCIM
24
TIAA CREF Investment Management
New York
$254K +$280K +14,352 New
Goldman Sachs
25
Goldman Sachs
New York
$242K +$267K +13,674 New
1
2

ENTA Hedge Fund Activity: Q2 2013 in Review

42 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q2 2013, worth a combined $60.9M.

Buyers outnumbered sellers: 42 funds opened new ENTA positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

  • 42 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $60.9M of Enanta Pharmaceuticals stock for Q2 2013.
  • 42 funds opened new Enanta Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +42 holders.

Based on aggregated 13F filings for Q2 2013.